Inactive Instrument
Mymetics Corporation Share Price Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4L 4L 4L 3L 6L 4.23Cr 6L 43.82L 17.04L 2.16Cr 16.47L 16.12L 6.94Cr | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 7.21Cr 6.41Cr 6Cr 5.43Cr 10Cr 694.98Cr 10Cr 72Cr 28Cr 354.48Cr 27Cr 26Cr 1.14TCr | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 19/11/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| +4.16% | +3.42% | +49.37% | +94.17% | 7.43TCr | |
| +2.76% | -1.16% | +23.05% | +83.03% | 5.7TCr | |
| +0.24% | -1.37% | +4.08% | +37.22% | 4.83TCr | |
| -3.76% | -0.93% | +327.90% | +691.25% | 4.45TCr | |
| -2.30% | -4.06% | +25.82% | +31.42% | 4.38TCr | |
| +0.31% | -1.15% | +5.50% | +112.56% | 4.11TCr | |
| -0.11% | +2.30% | +9.19% | +58.68% | 3.11TCr | |
| +4.51% | +8.43% | +37.27% | +34.97% | 2.9TCr | |
| -1.96% | -3.38% | -9.25% | -12.85% | 2.45TCr | |
| Average | -0.64% | -0.20% | +52.55% | +125.61% | 4.37TCr | |
| Weighted average by Cap. | +0.77% | -0.50% | +56.58% | +134.21% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 4L 4L 4L 3L 6L 4.14Cr 6L 42.94L 16.7L 2.11Cr 16.14L 15.79L 6.8Cr | 10.28L 9L 9L 8L 14.61L 9.91Cr 14.72L 1.03Cr 39.92L 5.05Cr 38.58L 37.76L 16Cr |
| Net income | -47.3L -42.01L -39.35L -35.63L -67.2L -46Cr -67.74L -4.72Cr -1.84Cr -23Cr -1.78Cr -1.74Cr -75Cr | -48.05L -42.67L -39.97L -36.2L -68.27L -46Cr -68.82L -4.8Cr -1.87Cr -24Cr -1.8Cr -1.76Cr -76Cr |
| Net Debt | 6.71Cr 5.96Cr 5.58Cr 5.05Cr 9.53Cr 646.58Cr 9.61Cr 67Cr 26Cr 329.8Cr 25Cr 25Cr 1.06TCr | 7.17Cr 6.37Cr 5.96Cr 5.4Cr 10Cr 690.75Cr 10Cr 72Cr 28Cr 352.33Cr 27Cr 26Cr 1.13TCr |
Employees
-
